PRECLINICAL TRIAL OF 4-AMINOPYRIDINE IN PATIENTS WITH CHRONIC SPINAL-CORD INJURY

被引：80

作者：

HAYES, KC

BLIGHT, AR

POTTER, PJ

ALLATT, RD

HSIEH, JTC

WOLFE, DL

LAM, S

HAMILTON, JT

机构：

[1] Department of Physical Medicine & Rehabilitation, Parkwood Hospital, London, ON, N6C 5JI

[2] Division of Neurosurgery, University of North Carolina, NC

[3] Department of Rehabilitation Nursing, Parkwood Hospital, London, ON

[4] Department of Pharmacology & Toxicology, The University of Western Ontario, London, ON

[5] The University of Western Ontario, London, ON

来源：

PARAPLEGIA | 1993年 / 31卷 / 04期

关键词：

SPINAL CORD INJURY; 4-AMINOPYRIDINE; DEMYELINATION; CONDUCTION BLOCK; PARALYSIS;

D O I：

10.1038/sc.1993.40

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

4-Aminopyridine (4-AP) is a K+ channel blocking agent that enhances nerve conduction through areas of demyelination by prolonging the duration of the action potential and increasing the safety factor for conduction. We have investigated the effects of 4-AP (24 mg total dose-intravenous) in 6 patients with spinal cord injury (3 complete, 3 incomplete) with the intent of overcoming central conduction block, or slowing, due to demyelination. Vital signs remained stable and only mild side effects were noted. The 3 patients with incomplete injuries all demonstrated enhanced volitional EMG interference patterns and one patient exhibited restored toe movements. The changes were reversed on drug washout. There were no changes in segmental reflex activities. These results are consistent with those obtained from 4-AP trials with animal models of spinal cord injury, showing modest therapeutic benefit attributable to enhanced central conduction.

引用

页码：216 / 224

页数：9

共 39 条

[1]

Holmes G., On the relation between loss of function and structural change in focal lesions of the central nervous system, with special reference to secondary degeneration, Brain, 29, pp. 514-523, (1906)

[2]

Harrison B.M., McDonald W.I., Remyelination after transient experimental compression of the spinal cord, Ann Neurol, 1, pp. 542-551, (1977)

[3]

Harrison B.M., Remyelination by cells introduced into a stable demyelinating lesion in the central nervous system, J Neurol Sci, 46, pp. 63-81, (1980)

[4]

Griffiths I.R., McCulloch M.C., Nerve fibers in spinal cord impact injuries. 1. Changes in the myelin sheath during the initial five weeks, J Neurol Sci, 58, pp. 335-345, (1983)

[5]

Blight A.R., Axonal physiology of chronic spinal cord injury in the cat, intracellular recording in vitro, Neuroscience, 10, pp. 1471-1486, (1983)

[6]

Blight A.R., Delayed demyelination and macrophage invasion: A candidate for ‘secondary' cell damage in spinal cord injury, Cent Nerv Sys Trauma, 2, pp. 299-315, (1985)

[7]

Gledhill R.F., Harrison B.M., McDonald W.I., Demyelination and remyelination after acute spinal cord compression, Exp Neural, 38, pp. 482-487, (1973)

[8]

Waxman S.G., Demyelination in spinal cord injury, J Neural Sci, 91, pp. 1-14, (1989)

[9]

Lemiegnan M., Millart H., Lamiable D., Molgo J., Lechat P., Evaluation of 4-aminopyridine and 3-4-diaminopyridine penetrability into cerebrospinal fluid in anesthetized rats, Brain Res, 304, pp. 166-169, (1986)

[10]

Sherratt R.M., Bostock H., Sears T.A., Effects of 4-aminopyridine on normal and demyelinated mammalian nerve fibers, Nature, 283, pp. 570-572, (1980)

← 1 2 3 4 →